Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1: Usage of esketamine spray for treatment-resistant major depressive disorder (MDD)
- Case 2: The man who is confused about his identity
- Case 3: Propane, shattered glass, and parasites
- Case 4: Hit by a car
- Case 5: Caring for the whole person
- Case 6: The man whom clozapine (Clozaril) could not touch
- Case 7: Where did her period go?
- Case 8: To dopamine or not to dopamine, that is the question
- Case 9: The one that came out of nowhere
- Case 10: Darth Vaper strikes again
- Case 11: First-time Mom’s struggle with postpartum post-traumatic stress disorder (PTSD)
- Case 12: Why so down?
- Case 13: It’s confusing, isn’t it?
- Case 14: The adolescent who just can’t stay awake
- Case 15: The lady with bipolar disorder (BP), borderline personality disorder (BPD), and myasthenia gravis (MG)
- Case 16: Spending money does not make a bipolar diagnosis
- Case 17: Pain makes me anxious, and anxiety gives me pain
- Case 18: The woman who couldn’t focus
- Case 19: The gentleman with sudden onset of akathisia on clozapine (Clozaril)
- Case 20: The pregnancy blues
- Case 21: The menopause blues
- Case 22: The lady who felt “funny” on the medication
- Case 23: Two ladies with bruises
- Case 24: The lady who was afraid for her kids
- Case 25: The woman whose kidneys could not handle lithium
- Case 26: The gentleman who was sober and could not focus
- Case 27: When the music does not stop
- Case 28: The man who tried to get it right
- Index of drug names
- Index of case studies
- References
Case 5: - Caring for the whole person
Published online by Cambridge University Press: 03 April 2024
Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1: Usage of esketamine spray for treatment-resistant major depressive disorder (MDD)
- Case 2: The man who is confused about his identity
- Case 3: Propane, shattered glass, and parasites
- Case 4: Hit by a car
- Case 5: Caring for the whole person
- Case 6: The man whom clozapine (Clozaril) could not touch
- Case 7: Where did her period go?
- Case 8: To dopamine or not to dopamine, that is the question
- Case 9: The one that came out of nowhere
- Case 10: Darth Vaper strikes again
- Case 11: First-time Mom’s struggle with postpartum post-traumatic stress disorder (PTSD)
- Case 12: Why so down?
- Case 13: It’s confusing, isn’t it?
- Case 14: The adolescent who just can’t stay awake
- Case 15: The lady with bipolar disorder (BP), borderline personality disorder (BPD), and myasthenia gravis (MG)
- Case 16: Spending money does not make a bipolar diagnosis
- Case 17: Pain makes me anxious, and anxiety gives me pain
- Case 18: The woman who couldn’t focus
- Case 19: The gentleman with sudden onset of akathisia on clozapine (Clozaril)
- Case 20: The pregnancy blues
- Case 21: The menopause blues
- Case 22: The lady who felt “funny” on the medication
- Case 23: Two ladies with bruises
- Case 24: The lady who was afraid for her kids
- Case 25: The woman whose kidneys could not handle lithium
- Case 26: The gentleman who was sober and could not focus
- Case 27: When the music does not stop
- Case 28: The man who tried to get it right
- Index of drug names
- Index of case studies
- References
Summary
Which of the following medications is FDA-approved for dissociative identity disorder (DID)?
Keywords
electroconvulsive therapy (ECT)dissociative identity disorder (DID)dialectical behavioral therapy (DBT)non-complianceborderline personality disorder (BPD)clozapine (Clozaril)amitriptyline (Elavil)lithium (Eskalith)fluoxetine (Prozac)quetiapine (Seroquel)escitalopram (Lexapro)aripiprazole (Abilify)paroxetine(Paxil)
- Type
- Chapter
- Information
- Case Studies: Stahl's Essential Psychopharmacology , pp. 71 - 86Publisher: Cambridge University PressPrint publication year: 2024
References
Blihar, D, Delgado, E, Buryak, M, et al. A systematic review of the neuroanatomy of dissociative identity disorder. Eur J Trauma Dissociation 2020; 4:100148CrossRefGoogle Scholar
Brand, BL, Sar, V, Stavropoulos, P, et al. Separating fact from fiction: an empirical examination of six myths about dissociative identity disorder. Harv Rev Psychiatry 2016; 24:257–70CrossRefGoogle ScholarPubMed
Brand, BL, Webermann, AR, Snyder, BL, et al. Detecting clinical and simulated dissociative identity disorder with the Test of Memory Malingering. Psychol Trauma 2019; 11:513–20CrossRefGoogle ScholarPubMed
Kalin, NH. Trauma, resilience, anxiety disorders, and PTSD. Am J Psychiatry 2021; 178:103–5CrossRefGoogle ScholarPubMed
Lebois, LAM, Li, M, Baker, JT, et al. Large-scale functional brain network architecture changes associated with trauma-related dissociation. Am J Psychiatry 2021; 178:165–73CrossRefGoogle ScholarPubMed
Menon, V. Dissociation by network integration. Am J Psychiatry 2021; 178:110–12CrossRefGoogle ScholarPubMed
Reinders, A, Marquand, AF, Schlumpf, YR, et al. Aiding the diagnosis of dissociative identity disorder: pattern recognition study of brain biomarkers. Br J Psychiatry 2019; 215:536–44CrossRefGoogle ScholarPubMed
Sadock, B, Sadock, V, Ruiz, P. Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. Philadelphia: Lippincott Williams & Wilkins, 2015Google Scholar
Stahl, SM. Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 5. Cambridge: Cambridge University Press, 2021CrossRefGoogle Scholar
Sutar, R, Sahu, S. Pharmacotherapy for dissociative disorders: a systematic review. Psychiatry Res 2019; 281:112529CrossRefGoogle ScholarPubMed